Search Results - david+stevens

2 Results

Sort By:

Polymeric Delivery Platform for Therapeutics

Abstract: Drug delivery technologies have long claimed the ability to selectively deliver therapeutic cargo to target cells. Despite advances in nanomedicine and drug delivery systems, there are no targeted nanoscale drug delivery technologies on the market. Thus, there is still tremendous potential in improved therapeutic efficacy when targeted drug...

Published: 4/22/2025 | Updated: 8/2/2023 | Inventor(s): David Stevens, Stephan Stern, Scott McNeil, Marina Dobrovolskaia

Keywords(s): Drug Delivery, Immunotherapy, Scavenger Receptor A1, SR-A1

Category(s): Application > Therapeutics, TherapeuticArea > Infectious Disease, TherapeuticArea > Immunology, TherapeuticArea > Neurology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Oncology

Size-dependent brain distribution of macromolecular drug delivery platform

Summary: The NCI seeks research co-development partners and/or licensees for a selective polylysine succinylated (PLS) drug delivery platform. Description of Technology: The blood brain barrier (BBB) is a specialized endothelium that prevents the uptake of substances from the systemic circulation into the central nervous system. This barrier, while...

Published: 4/24/2026 | Updated: 8/2/2023 | Inventor(s): Stephan Stern, David Stevens

Keywords(s): BBB, Blood-brain Barrier, Brain Cancer, Controlled Drug Release, Drug Delivery Platform, Neurological Disorders, Stern

Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Neurology